trending Market Intelligence /marketintelligence/en/news-insights/trending/0ctQtT0wbg0DeoTiQvp2KA2 content esgSubNav
In This List

InVivo Therapeutics CEO resigns

Blog

Insight Weekly: Bank boards lag on gender parity; future of office in doubt; US LNG exports leap

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch

Blog

Perspectives from China: Chinese M&A in 2022


InVivo Therapeutics CEO resigns

InVivo Therapeutics Holdings Corp. CEO Mark Perrin is resigning, to be replaced by Richard Toselli on an acting basis.

Ann Merrifield will replace Perrin as the chair of the company's board. Merrifield was previously the company's lead director.

Toselli currently serves as InVivo's chief medical officer and he will continue to do so.